The field of pancreatic cancer biology has benefited tremendously from the development of spontaneous mouse models of pancreatic carcinogenesis, which feature pancreas-specific endogenous expression of oncogenic Kras and the tumor suppressor p53, and faithfully recapitulate formation and histopathological progression of PDA to metastasis2,3. This evidence concerns the gene KRAS and Patent ductus arteriosus.